Blueshift Asset Management »

Iovance Biotherapeutics shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $141k 40k 3.51
2025-06-30 $38k 22k 1.72
2019-12-31 $309k 11k 27.72
2018-12-31 $215k 24k 8.84

More positions owned by Blueshift Asset Management

Ishares Tr Russell 2000 Etf (IWM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Etsy (ETSY)
Avis Budget (CAR)
Match Group (MTCH)
O'reilly Automotive (ORLY)
Five Below (FIVE)
Murphy Usa (MUSA)
Equifax (EFX)
CarMax (KMX)
Nike CL B (NKE)
Walt Disney Company (DIS)
Affirm Hldgs Com Cl A (AFRM)
Target Corporation (TGT)
Royal Caribbean Cruises (RCL)

View all positions for Blueshift Asset Management

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors
Morgan Stanley

View all funds holding Iovance Biotherapeutics